"That's the billion-dollar question, " says Santarelli, who is holding off testing his drug in autism until researchers know more.

FORBES: Magazine Article

"My dream would be to apply the treatments early enough in life so we could change the course of the disease, " says Roche Vice President Luca Santarelli.

FORBES: Magazine Article